- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Nov 22, 2019
Preclinical News
Nov. 21 Preclinical Quick Takes: Excision applies CRISPR editing to herpes, John Cunningham viruses; plus Caribou, Oligomerix, Kymab and Gladstone-Boston Univer
BioCentury | Nov 30, 2018
Targets & Mechanisms
Souped-up CARs at ASH 2018
How modifications to CAR T and CAR NK cells stand to boost their function
BioCentury | May 24, 2018
Preclinical News
miRNA-targeted circular single-stranded DNA to treat cancer
BioCentury | Apr 6, 2018
Targets & Mechanisms
GI Band-Aid
How preventing bacteria from escaping the gut could treat autoimmunity
BioCentury | Aug 17, 2017
Finance
Built to purpose
How build-to-buy deals are reaching an inflection point
BioCentury | Mar 30, 2017
Translation in Brief
An E3 for TNBC
Why an E3 ligase could be a potent target for triple-negative breast cancer
BioCentury | May 16, 2016
Emerging Company Profile
EMT interrupted
How Oncodrone molecule could prevent cancer metastases
BioCentury | Mar 24, 2016
Distillery Techniques
Techniques: E-cadherin (CDH1; CD324) mutations as diagnostic markers of plasmacytoid bladder cancer
Items per page:
1 - 10 of 23